BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-858@pharmaconomics
DTSTAMP:20260707T025359Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:ARDX Phase 3 — tenapanor (estimated date)
DESCRIPTION:Phase 3 trial results for tenapanor in irritable bowel syndrome with constipation (IBS-C) are due ~ Dec 31\, 2029. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1437402/000143740226000012/ardx-20251231xexhibit992.htm\n\nTrack it: https://pharmaconomics.com/e/858
URL:https://pharmaconomics.com/e/858
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ARDX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR